Related Experiment Video
Updated: Jul 3, 2025

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
Published on: February 18, 2022
Back to the basics: The need for an etiological classification of chronic heart failure
Filippos Triposkiadis1, Andrew Xanthopoulos2, Stavros G Drakos3
1School of Medicine, European University Cyprus, Nicosia 2404, Cyprus; Department of Cardiology, University Hospital of Larissa, Larissa 41110, Greece.
Insights
The traditional left ventricular ejection fraction (LVEF) classification for heart failure (HF) is outdated. New evidence suggests an etiological approach is better for guiding HF treatment and precision medicine.
Area of Science:
- Cardiology
- Heart Failure Research
- Clinical Medicine
Background:
- The left ventricular ejection fraction (LVEF) has long been central to heart failure (HF) classification and management.
- This classification has been favored because it identifies patient groups benefiting from specific treatments.
Purpose of the Study:
- To review evidence challenging the utility of LVEF in HF classification.
- To advocate for a shift towards contemporary concepts in guiding chronic HF treatment.
Main Methods:
- Review of current evidence regarding LVEF in HF classification and treatment guidance.
- Analysis of the limitations of LVEF in guiding medical, device, and mechanical circulatory support therapies.
- Proposal of an alternative etiologic HF classification.
Main Results:
- The rationale for LVEF-based HF classification has weakened, as neurohormonal inhibitors benefit most HF patients irrespective of LVEF.
- LVEF is a poor predictor for device therapies like implantable cardioverter-defibrillators and cardiac resynchronization therapy.
- LVEF is an inadequate surrogate for LV size in LV assist device implantation.
Conclusions:
- The reliance on LVEF for HF classification and treatment guidance is increasingly untenable.
- A transition to etiologic HF classification, based on epidemiological data, is proposed.
- This new classification will support higher-resolution phenotyping for precision medicine in HF.
Abstract:
The left ventricular (LV) ejection fraction (LVEF), despite its severe limitations, has had an epicentral role in heart failure (HF) classification, management, and risk stratification for decades. The major argument favoring the LVEF based HF classification has been that it defines groups of patients in which treatment is effective. However, this reasoning has recently collapsed, since medical treatment with neurohormonal inhibitors, has proved beneficial in most HF patients regardless of the LVEF. In addition, there has been compelling evidence, that the LVEF provides poor guidance for device treatment of chronic HF (implantation of cardioverter defibrillator, cardiac resynchronization therapy) since sudden cardiac death may occur and cardiac dyssynchronization may be disastrous in all HF patients. The same holds true for LV assist device implantation, in which the LVEF has been used as a surrogate for LV size. In this review article we update the evidence questioning the use of LVEF-based HF classification and argue that guidance of chronic HF treatment should transition to more contemporary concepts. Specifically, we propose an etiologic chronic HF classification predominantly based on epidemiological data, which will be foundational for further higher resolution phenotyping in the emerging era of precision medicine.
Related Concept Videos
Pathophysiology of Heart Failure
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Heart Failure Drugs: β-Blockers
Cardiovascular Drugs: Classification based on Therapeutic Indications
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

